Alexion Pharmaceuticals
0 sources
Financials
0000899866-21-000014Alexion Pharmaceuticals
Summary
Alexion Pharmaceuticals is a business[1]. It ranks in the top 4% of business entities by monthly Wikipedia readership (241 views/month).[2]
Key Facts
- Alexion Pharmaceuticals is in the country of United States[3].
- Alexion Pharmaceuticals's instance of is recorded as business[4].
- Alexion Pharmaceuticals's instance of is recorded as enterprise[5].
- Alexion Pharmaceuticals's instance of is recorded as public company[6].
- Alexion Pharmaceuticals's headquarters location is recorded as Cheshire[7].
- Alexion Pharmaceuticals's child organization or unit is recorded as Alexion Pharma (Switzerland)[8].
- Alexion Pharmaceuticals's stock exchange is recorded as Nasdaq[9].
- Alexion Pharmaceuticals's industry is recorded as pharmaceutical industry[10].
- January 1, 1992 marks the founding of Alexion Pharmaceuticals[11].
- Alexion Pharmaceuticals's location of formation is recorded as Boston[12].
- Alexion Pharmaceuticals's parent organization or unit is recorded as AstraZeneca[13].
- Alexion Pharmaceuticals's official website is recorded as https://alexion.com/[14].
- Alexion Pharmaceuticals's official website is recorded as http://www.alexion.com[15].
- Alexion Pharmaceuticals's product or material produced is recorded as Soliris[16].
- Alexion Pharmaceuticals's product or material produced is recorded as Kanuma[17].
- Alexion Pharmaceuticals's product or material produced is recorded as ravulizumab[18].
- Alexion Pharmaceuticals's product or material produced is recorded as Strensiq[19].
- Alexion Pharmaceuticals's employees is recorded as {'amount': '+3837'}[20].
- Alexion Pharmaceuticals's employees is recorded as {'amount': '+2656'}[21].
- Alexion Pharmaceuticals's employees is recorded as {'amount': '+3082'}[22].
- Alexion Pharmaceuticals's legal form is recorded as Delaware corporation[23].
- Alexion Pharmaceuticals's short name is recorded as {'lang': 'en', 'text': 'Alexion'}[24].
- Alexion Pharmaceuticals's total revenue is recorded as {'unit': 'Q4917', 'amount': '+6069900000'}[25].
- Alexion Pharmaceuticals's total revenue is recorded as {'unit': 'Q4917', 'amount': '+4991100000'}[26].
- Alexion Pharmaceuticals's total revenue is recorded as {'unit': 'Q4917', 'amount': '+4131200000'}[27].
Body
Founding
January 1, 1992 marks the founding of Alexion Pharmaceuticals[11]. Its location of formation is recorded as Boston[12].
Identity
Alexion Pharmaceuticals's short name is recorded as {'lang': 'en', 'text': 'Alexion'}[24].
Operations
Alexion Pharmaceuticals's headquarters location is recorded as Cheshire[7]. Its parent organization or unit is recorded as AstraZeneca[13]. Its child organization or unit is recorded as Alexion Pharma (Switzerland)[8].
Industry
Alexion Pharmaceuticals's industry is recorded as pharmaceutical industry[10].
Ownership
Alexion Pharmaceuticals's stock exchange is recorded as Nasdaq[9]. Products include Soliris[16], Kanuma[17], ravulizumab[18], and Strensiq[19].
Why It Matters
Alexion Pharmaceuticals ranks in the top 4% of business entities by monthly Wikipedia readership (241 views/month).[2] It has Wikipedia articles in 11 language editions, a strong signal of global cultural recognition.[28] It is known by 8 alternative names across languages and contexts.[29]